Skip to main content

Table 4 Response rate evaluated by site of metastasis

From: Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study

  Number of responsive lesions Number of evaluable lesions Response rate (%)
Liver 26 39 66.7
Lung 10 18 55.6
Lymph node 39 54 72.2
Skin 5 8 62.5
Others 9 20 45.0